Prognostic Factors for Pectus Carinatum Treated by Dynamic Compression System: PECTUSDYN Trial
European Journal of Cardio-Thoracic Surgery · 2026
DOI: 10.1093/ejcts/ezaf444 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift European Journal of Cardio-Thoracic Surgery, 2026. Verfasst von Lorraine Kieffer De Marco und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Surgery, University Hospital of Saint-Etienne, Saint-Priest-en-Jarez, France. Hauptthemen laut MEDLINE: Braces, Pectus Carinatum. Die Arbeit nennt 20 Literaturangaben. Gefördert von: University Hospital of Saint-Etienne.
Abstract (Originalsprache)
Objectives
Dynamic compression bracing (DCB) systems have been proven safe and effective for non-surgical treatment of pectus carinatum (PC). This study aimed to identify potential prognostic factors for correcting PC using DCB.
Methods
From 2011 to 2020, all patients treated with DCB for PC at the University Hospital of Saint-Etienne were reviewed retrospectively. The primary outcome was a ≤50% reduction in pectus height (PH) at the 6-month follow-up, measured by radiation-free imaging. Two statistical models adjusted for compliance with treatment were used.
Results
A total of 297 patients were treated with DCB (mean age: 15.4 ± 3.9 years). A total of 42% of deformities were symmetrical. Baseline mean PH and pressure for initial correction (PIC) were 2.97 ± 1.02 cm and 6.5 ± 2.0 psi, respectively. The median total treatment duration was 13.1 months (9.2-17.9). Among the 114 (46.5%) patients with available PH data, the median decrease in PH was –35.8% (–62.4% to –10.0%) after 6 months of DCB, with 61 patients (53.5%) achieving a reduction ≥ 50% in PH. In multivariate analysis, only PIC (odds ratio = 1.34; 95% confidence interval, 1.09-1.64; P = .005) was significantly associated with PH reduction in model 1, and PIC ≥ 7.5 psi (odds ratio = 2.53; 95% confidence interval, 1.13-5.67; P = .024) in model 2. Patient compliance was 85.2% at 6 months. The recurrence rate was 11.3% (n = 26).
Conclusions
The PIC value appears to be a potential prognostic factor for PH reduction after 6 months of treatment with DCB. These results will be validated in an ongoing prospective study. Clinical trial The study was approved by the ethical committee “Terres d’Ethique” (IRBN902020/CHUSTE) and registered at Clinicaltrials.gov (NCT04452721).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatric Surgery, University Hospital of Saint-Etienne, Saint-Priest-en-Jarez, France.
- Department of Thoracic Surgery, University Hospital of Saint Etienne, Saint-Priest-en-Jarez, France.
- Department of Clinical Pharmacology and Clinical Research Unit, University Hospital of Saint-Etienne, Saint-Priest-en-Jarez, France.
- INSERM UMR 1059 SAINBIOSE, Jean-Monnet University, Mines Saint-Étienne, Saint-Étienne, France.
ORCID-Profile: Lorraine Kieffer De Marco, Sophie Vermersch
Förderung
- University Hospital of Saint-Etienne
Zitieren
APA
Kieffer De Marco, L., Filaire, L., Vermersch, S., Chapelle, C., Garcin, A., Tiffet, O., & Scalabre, A. (2026). Prognostic Factors for Pectus Carinatum Treated by Dynamic Compression System: PECTUSDYN Trial. European Journal of Cardio-Thoracic Surgery. https://doi.org/10.1093/ejcts/ezaf444
Vancouver
Kieffer De Marco L, Filaire L, Vermersch S, Chapelle C, Garcin A, Tiffet O, et al. Prognostic Factors for Pectus Carinatum Treated by Dynamic Compression System: PECTUSDYN Trial. European Journal of Cardio-Thoracic Surgery. 2026. doi:10.1093/ejcts/ezaf444
BibTeX
@article{KiefferDeMarco2026,
author = {Kieffer De Marco, Lorraine and Filaire, Laura and Vermersch, Sophie and Chapelle, Céline and Garcin, Arnauld and Tiffet, Olivier and Scalabre, Aurélien},
title = {Prognostic Factors for Pectus Carinatum Treated by Dynamic Compression System: PECTUSDYN Trial},
journal = {European Journal of Cardio-Thoracic Surgery},
year = {2026},
doi = {10.1093/ejcts/ezaf444}
}
EUVIMED